HUP0402023A2 - Anasztrozol felhasználása korai stádiumú emlőrákban szenvedő, véglegessé vált menopauzájú nőbetegek kezelésére alkalmas gyógyszerkészítmények előállításához - Google Patents

Anasztrozol felhasználása korai stádiumú emlőrákban szenvedő, véglegessé vált menopauzájú nőbetegek kezelésére alkalmas gyógyszerkészítmények előállításához

Info

Publication number
HUP0402023A2
HUP0402023A2 HU0402023A HUP0402023A HUP0402023A2 HU P0402023 A2 HUP0402023 A2 HU P0402023A2 HU 0402023 A HU0402023 A HU 0402023A HU P0402023 A HUP0402023 A HU P0402023A HU P0402023 A2 HUP0402023 A2 HU P0402023A2
Authority
HU
Hungary
Prior art keywords
anastrozole
breast cancer
post
preparation
treatment
Prior art date
Application number
HU0402023A
Other languages
English (en)
Inventor
Paul Plourde
Anthony Rogers
Brent Vose
Michael Dukes
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9927290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0402023(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HUP0402023A2 publication Critical patent/HUP0402023A2/hu
Publication of HUP0402023A3 publication Critical patent/HUP0402023A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Chemical Treatment Of Metals (AREA)

Abstract

A találmány tárgya az anasztrozol vagy gyógyászatilag alkalmazható sóifelhasználása korai stádiumú emlőrákban szenvedő, véglegessé váltmenopauzájú nőbetegeken a rák kiújulási arányának és/vagy újellenoldali primer tumor kialakulási arányának csökkentésére alkalmasgyógyszerkészítmények gyártásához. Ó
HU0402023A 2001-12-10 2002-12-06 Use of anastrozole in the preparation of pharmaceutical compositions for the treatment of post-menopausal women having early breast cancer HUP0402023A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0129457.8A GB0129457D0 (en) 2001-12-10 2001-12-10 Method of treatment
PCT/GB2002/005554 WO2003053438A1 (en) 2001-12-10 2002-12-06 Use of anastrozole for the treatment of post-menopausal women having early breast cancer

Publications (2)

Publication Number Publication Date
HUP0402023A2 true HUP0402023A2 (hu) 2005-01-28
HUP0402023A3 HUP0402023A3 (en) 2008-08-28

Family

ID=9927290

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0402023A HUP0402023A3 (en) 2001-12-10 2002-12-06 Use of anastrozole in the preparation of pharmaceutical compositions for the treatment of post-menopausal women having early breast cancer

Country Status (29)

Country Link
US (1) US20050165081A1 (hu)
EP (2) EP1455781B1 (hu)
JP (2) JP5335173B2 (hu)
KR (1) KR100858946B1 (hu)
CN (1) CN100408036C (hu)
AT (1) ATE406160T1 (hu)
AU (1) AU2002347371B2 (hu)
BR (1) BR0214798A (hu)
CA (1) CA2468965C (hu)
CO (1) CO5590926A2 (hu)
CY (1) CY1108462T1 (hu)
DE (1) DE60228616D1 (hu)
DK (1) DK1455781T3 (hu)
ES (1) ES2303811T3 (hu)
GB (1) GB0129457D0 (hu)
HK (1) HK1069335A1 (hu)
HU (1) HUP0402023A3 (hu)
IL (1) IL162150A0 (hu)
IS (1) IS7300A (hu)
MX (1) MXPA04005394A (hu)
NO (1) NO20042912L (hu)
NZ (1) NZ533106A (hu)
PL (1) PL369411A1 (hu)
PT (1) PT1455781E (hu)
RU (1) RU2320339C2 (hu)
SI (1) SI1455781T1 (hu)
UA (1) UA79443C2 (hu)
WO (1) WO2003053438A1 (hu)
ZA (1) ZA200404260B (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0129457D0 (en) * 2001-12-10 2002-01-30 Astrazeneca Ab Method of treatment
US8436029B2 (en) * 2004-03-19 2013-05-07 Transform Pharmaceuticals, Inc. Pharmaceutical forms, and methods of making and using the same
WO2005117864A1 (en) * 2004-05-28 2005-12-15 Astrazeneca Ab Combination product comprising anastrozole and a dual prenyl transferase inhibitor
CN100337625C (zh) * 2004-08-30 2007-09-19 鲁南制药集团股份有限公司 阿那曲唑的分散片剂型
CN1304054C (zh) * 2004-12-29 2007-03-14 山东蓝金生物工程有限公司 一种缓慢释放的抗癌药物组合物
GB0517674D0 (en) * 2005-08-31 2005-10-05 Astrazeneca Ab Formulation
GB0517673D0 (en) * 2005-08-31 2005-10-05 Astrazeneca Ab Formulation
WO2011130381A1 (en) * 2010-04-13 2011-10-20 Estrocept Diagnostics, Inc. Diagnostic assays for breast cancer treatment and progression
US10201549B2 (en) 2013-06-14 2019-02-12 Professional Compounding Centers Of America (Pcca) Testosterone combined with anastrozole injection solutions
CN103450099B (zh) * 2013-09-06 2015-03-25 杭州华东医药集团新药研究院有限公司 阿那曲唑及其一水合物的新晶型、制备和用途
RU2548722C1 (ru) * 2013-12-06 2015-04-20 Федеральное государственное бюджетное учреждение "Национальный исследовательский центр "Курчатовский институт" Противоопухолевое лекарственное средство пролонгированного действия на основе противоопухолевого препарата, ингибитора синтеза эстрогенов - анастрозола
DE102014005513B4 (de) * 2014-04-15 2018-03-15 Sanoxsys Gmbh Mittel zur Prävention und Therapie von Tumorerkrankungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714013D0 (en) * 1987-06-16 1987-07-22 Ici Plc (substituted-aralkyl)heterocyclic compounds
AR034142A1 (es) * 2000-09-08 2004-02-04 Sloan Kettering Inst Cancer Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion
GB0129457D0 (en) * 2001-12-10 2002-01-30 Astrazeneca Ab Method of treatment

Also Published As

Publication number Publication date
CA2468965A1 (en) 2003-07-03
RU2004121162A (ru) 2005-05-20
NO20042912L (no) 2004-08-25
DK1455781T3 (da) 2008-11-24
HK1069335A1 (en) 2005-05-20
UA79443C2 (en) 2007-06-25
JP2011016828A (ja) 2011-01-27
ATE406160T1 (de) 2008-09-15
ES2303811T3 (es) 2009-02-01
CO5590926A2 (es) 2005-12-30
NZ533106A (en) 2008-02-29
CN1630519A (zh) 2005-06-22
RU2320339C2 (ru) 2008-03-27
ES2303811T1 (es) 2008-09-01
MXPA04005394A (es) 2005-04-19
DE60228616D1 (de) 2008-10-09
CA2468965C (en) 2011-08-30
IL162150A0 (en) 2005-11-20
JP5335173B2 (ja) 2013-11-06
EP1455781A1 (en) 2004-09-15
US20050165081A1 (en) 2005-07-28
PL369411A1 (en) 2005-04-18
JP2005516021A (ja) 2005-06-02
BR0214798A (pt) 2004-10-19
EP1455781B1 (en) 2008-08-27
IS7300A (is) 2004-06-04
AU2002347371A1 (en) 2003-07-09
KR100858946B1 (ko) 2008-09-17
KR20040066886A (ko) 2004-07-27
AU2002347371B2 (en) 2007-05-10
GB0129457D0 (en) 2002-01-30
HUP0402023A3 (en) 2008-08-28
CN100408036C (zh) 2008-08-06
EP1997492A1 (en) 2008-12-03
WO2003053438A1 (en) 2003-07-03
SI1455781T1 (sl) 2008-12-31
PT1455781E (pt) 2008-11-03
CY1108462T1 (el) 2014-04-09
ZA200404260B (en) 2005-10-26

Similar Documents

Publication Publication Date Title
HK1069335A1 (en) Use of anastrozole for the treatment of post-menopausal women having early breast cancer
Spitler A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma.
RU2007145489A (ru) Фармацевтические композиции и способы лечения рака и его метастазов
MY127290A (en) New use of flibanserin
HUP0401903A2 (hu) Az ET-743 továbbfejlesztett alkalmazása daganatok kezelésére
BR0213684A (pt) Uso de antagonistas do receptor de endotelina para o tratamento de doenças tumorìgenas
HUP9802066A2 (hu) Alendronát alkalmazása csigolyát nem érintő csonttörések kockázatát csökkentő gyógyszerkészítmények előállítására
HUP9701777A2 (hu) Raloxifene alkalmazása mellrák megelőzésére alkalmas gyógyszerkészítmények előállítására
BR0311146A (pt) Uso de tibolona e de modulador de receptor de estrogênio seletivo, e, método e kit para o tratamento de um sintoma relacionado com a deficiência de estrogênio em um paciente do sexo feminino
CA3100422A1 (en) Dosing regimens for treatment of solid tumors having one or more genetic alterations in fgfr1, fgfr2, and/or fgfr3
Girard et al. Occurrence of vismodegib-induced cramps (muscular spasms) in the treatment of basal cell carcinoma: A prospective study in 30 patients
Gershanovich et al. Clinical Data on the Antitumor Activity of Hydrazine Sulfate ¹, 2
HUP0401798A2 (hu) Rosuvastatin alkalmazása demencia előtti állapotokban használható gyógyszerkészítmény előállítására
HUP0302293A2 (hu) Rák kezelése aplidin és egy izomvédő szer együttes alkalmazásával
PT1401446E (pt) Derivados de tetrahidroquinolina para a inibicao de doencas associadas com a privacao de estrogenio ou com uma resposta fisiologica aberrante ao estrogenio endogeno
EP1773451B1 (en) Use of 7-t-butoxyiminomethylcamptothecin for treating uterine neoplasms
HUP0401731A2 (hu) N,N-dietil-2-[4-(fenilmetil)-fenoxi] etánamin-monohidroklorid (DPPE) alkalmazása a rákterápiában használható gyógyszer előállítására
NZ538926A (en) Medicament containing disorazoles and derivatives thereof for the treatment of benign and malignant tumoral diseases
OKABE et al. A case of a solitary fibrous tumor of the oral cavity
徐兵河 et al. THE CLINICAL COURSE AND TREATMENT RESULTS OF LUNG METASTASES FROM BREAST CANCER
Houghton et al. Arimidex, tamoxifen alone or in combination (ATAC) adjuvant trial in post-menopausal breast cancer
RS20050793A (sr) 8beta-vinil-11beta-(omega- supstituisani)alkil-estra-1,3,5 (10)- trieni
黄维庭 et al. FEMALE LARYNGOCARCINOMA (CLINICAL ANALYSIS OF 267 CASES)
Chmielowski et al. Skin Cancers
DE50113276D1 (de) Expression der keratingene 8 und 18 zur therapie von tumoren, insbesondere des mammakarzinoms

Legal Events

Date Code Title Description
FC4A Lapse of provisional application due to refusal